US Stock MarketDetailed Quotes

NRXP NRX Pharmaceuticals

Watchlist
  • 2.3500
  • +0.2800+13.53%
Close Mar 14 16:00 ET
  • 2.3500
  • 0.00000.00%
Post 18:24 ET
39.75MMarket Cap-1.11P/E (TTM)

About NRX Pharmaceuticals Company

NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.

Company Profile

SymbolNRXP
Company NameNRX Pharmaceuticals
Listing DateDec 1, 2017
Founded2017
CEODr. Jonathan C. Javitt,M.D.,M.P.H.
MarketNASDAQ
Fiscal Year Ends12-31
Address1201 Orange Street,Suite 600
CityWilmington
ProvinceDelaware
CountryUnited States of America
Zip Code19801
Phone1-484-254-6134

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jonathan C. Javitt,M.D.,M.P.H.
  • Chairman of the Board, Chief Scientist and Interim Chief Executive Officer
  • 630.20K
  • Matthew Duffy
  • Chief Business Officer
  • --
  • Michael S. Abrams
  • Chief Financial Officer
  • --
  • Dr. Riccardo Panicucci, PhD
  • Chief Manufacturing and Technology Officer and Technical Operations Advisor
  • --
  • Mike Taylor
  • Director
  • --
  • Dr. Dennis McBride, PhD
  • Director
  • --
  • Patrick J. Flynn
  • Independent Director
  • 67.50K
  • Chaim Hurvitz
  • Independent Director
  • 52.50K
Trending Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.